Kojin Therapeutics Raises $60 Million in Series A Funding to Develop New Category of Drugs Based on Cell State Biology

Founded by leading scientists, including Stuart Schreiber and Benjamin Cravatt Series A led by Polaris Partners, Newpath Partners and Cathay Health, the global cross-border platform affiliated with Cathay Capital with deep expertise in the healthcare, life sciences and technology Proprietary approach to drug discovery and development based on cell state and ferroptosis biology   CAMBRIDGE, […]